Immunic Inc. buy Roth Capital
Start price
07.11.25
/
50%
€0.60
Target price
07.11.26
€2.60
Performance (%)
-18.81%
Price
23.12.25
€0.49
Summary
This prediction is currently active. The price of Immunic Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -18.81%. This prediction currently runs until 07.11.26. The prediction end date can be changed by Roth_Capital at any time. Roth_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Immunic Inc. | -1.621% | -1.621% |
| iShares Core DAX® | 0.224% | 2.457% |
| iShares Nasdaq 100 | 0.371% | -0.320% |
| iShares Nikkei 225® | 0.972% | -0.829% |
| iShares S&P 500 | 0.417% | -0.157% |
Comments by Roth_Capital for this prediction
In the thread Immunic Inc. diskutieren
Immunic (NASDAQ:IMUX) is now covered by analysts at Roth Capital. They set a "buy" rating and a $3.00 price target on the stock.
Ratings data for IMUX provided by MarketBeat